Vaxart VXRT
OTC VXRT
$0.44 -0.04 (-8.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Vaxart (VXRT) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Vaxart (VXRT) recorded Return on Capital Employed [ROCE] of 39.81% in Q2 2026, up 167.57 percentage points from -127.76% a year earlier and up 3.86 percentage points from the prior quarter.

Analysis

Vaxart (VXRT) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Vaxart reported Return on Capital Employed [ROCE] of 20.20%, up 193.60 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +56.53 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -173.40% in FY2024 (-97.01 pp), -76.38% in FY2023 (-8.82 pp), -67.57% in FY2022 (-26.25 pp) and -41.31% in FY2021 (-4.98 pp).
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2011.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of +24.62 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 167.57 percentage points in Q2 2026, against a drop of 163.55 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 35.94% (Q1 2026), 16.32% (Q4 2025) and -283.36% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Vaxart 106.85 Mn 42.85 Mn - 39.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.81%
Mar 31, 2026 35.94%
Dec 31, 2025 16.32%
Sep 30, 2025 -283.36%
Jun 30, 2025 -127.76%
Mar 31, 2025 -89.35%
Dec 31, 2024 -87.63%
Sep 30, 2024 -119.81%
Jun 30, 2024 -87.82%
Mar 31, 2024 -107.50%
Dec 31, 2023 -98.04%
Sep 30, 2023 -94.85%
Jun 30, 2023 -97.17%
Mar 31, 2023 -91.45%
Dec 31, 2022 -78.13%
Sep 30, 2022 -68.73%
Jun 30, 2022 -54.57%
Mar 31, 2022 -41.06%
Dec 31, 2021 -33.01%
Sep 30, 2021 -27.83%
API Access

Vaxart Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VXRT&period=max&api_key=YOUR_API_KEY